About the Authors

Catharina Lavebratt

catharina.lavebratt@ki.se

Affiliation Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet at Karolinska University Hospital Solna, Stockholm, Sweden

Louise K. Sjöholm

Affiliation Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet at Karolinska University Hospital Solna, Stockholm, Sweden

Pia Soronen

Affiliation Public Health Genomics Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland

Tiina Paunio

Affiliation Public Health Genomics Unit, Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland

Marquis P. Vawter

Affiliation Functional Genomics Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine School of Medicine, Irvine, California, United States of America

William E. Bunney

Affiliation Functional Genomics Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine School of Medicine, Irvine, California, United States of America

Rolf Adolfsson

Affiliation Division of Psychiatry, Department of Clinical Sciences, University of Umeå, Umeå, Sweden

Yvonne Forsell

Affiliation Department of Public Health Science, Karolinska Institutet at Karolinska University Hospital Solna, Stockholm, Sweden

Joseph C. Wu

Affiliation Functional Genomics Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine School of Medicine, Irvine, California, United States of America

John R. Kelsoe

Affiliation Department of Psychiatry, University of California San Diego School of Medicine, La Jolla, California, United States of America

Timo Partonen

Affiliation Mood, Depression and Suicidal Behaviour Unit, Department of Mental Health and Substance Abuse Services, National Institute for Health and Welfare, Helsinki, Finland

Martin Schalling

Affiliation Neurogenetics Unit, Department of Molecular Medicine and Surgery, Karolinska Institutet at Karolinska University Hospital Solna, Stockholm, Sweden

Competing Interests

Dr. Vawter is a co-founder of a diagnostic testing company AbaStar MDx, Dr. Kelsoe is consultant for AstraZeneca, on speakers bureau for Merck, and founder, board member and hold equity in diagnostic testing company Psynomics, all in compliance with UCSD guidelines. Dr. Bunney is a member of the scientific advisory boards of NeoSync, Inc., CNS Response, Inc. and Thuris Corporation and consultant for NeuDezine. None of these commercial affiliations played any role in this study.

Author Contributions

Conceived and designed the experiments: CL TP MS. Performed the experiments: LS PS MV RA. Analyzed the data: CL LS PS TP MV WEB YF JW JK TP MS. Contributed reagents/materials/analysis tools: CL TP MV WEB RA YF JW JK TP MS. Wrote the paper: CL LS PS TP MV WEB RA YF JW JK TP MS.